The effects of Ginger (Zinger offiicinale Roscoe) on the prevention of PVC in patients with palpitation

Status

Recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT20220516054874N13

Enrollment

Registered

2023-10-11

Start date

2023-10-07

Completion date

Unknown

Last updated

2023-10-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Palpitations. Palpitations

Interventions

Intervention 1: Intervention group: Patients with heart palpitations receiving capsule containing ginger rhizome powder at a dose of 250 mg once daily for 10 days. Intervention 2: Control group: Patie

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: Patients with heart palpitations The number of PVCs during one day less than 15% in the 24-hour Holter rhythm Consent to admission to the study;

Exclusion criteria

Exclusion criteria: Previous history of heart palpitations History of receiving medications for PVC Structural heart disorder Stomach ulcers or duodenal ulcers Taking anticoagulants such as warfarin, aspirin and enoxaparin Breastfeeding or pregnancy Consumption of omega 3 (fish oil), ciprofloxacin, loratadine, citalopram, montelukast, and levothyroxine Kidney stone History of taking medicines containing ginger

Design outcomes

Primary

Measure	Time frame
The number of PVCs during 24 h. Timepoint: Before intervention and 10 days after beginning the intervention. Method of measurement: 24-hour Holter rhythm.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactDr. Vafa Baradaran Rahimi

Mashhad University of Medical Sciences

baradaranrv@mums.ac.ir0095 5138012739

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026